ArticleACS medicinal chemistry letters2019

Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease".

Angela De Simone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.